window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 13, 2025

  • News
  • About Us
Contact Us

GMP Manufacturing

  • CDMOs & Manufacturing,Cell & Gene Therapy

    Innovations driving efficient adherent cell cultivation in biotech

    Scaling adherent cell culture from early-stage research to commercial manufacturing [...]

    July 10, 2025
  • Biologics & Biosimilars,Clinical Trials,Drug Development,Patient Centricity

    Ciloa lands €6.5 million (£5.7 million) government backing to develop novel obesity and diabetes bio-drug

    Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

    July 8, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation

    Inside Biosynth’s bold Berlin bet on bioconjugation

    The new cleanroom suite boosts GMP capabilities to support conjugated [...]

    July 3, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Oncology,Partnerships & Funding

    eXmoor and Signadori Bio partner to advance monocyte-based cell therapy for solid tumours

    New alliance focuses on translation, process development and GMP-readiness for [...]

    July 1, 2025
  • CDMOs & Manufacturing,Drug Development,Oncology,Technology and platforms

    Orano Med invests $5M to expand US radiopharma capabilities

    Orano Med has expanded its US research and development center [...]

    June 27, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Partnerships & Funding,Technology and platforms

    Mabion manufactures first batch of NovalGen’s bispecific T-cell engager for clinical trials

    Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

    June 27, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Regulatory Affairs

    Is Europe rising? How global pharma uncertainty is fuelling a new era for European innovation

    As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

    June 8, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Trials

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 27, 2025
  • Cell & Gene Therapy

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 13, 2025
  • Partnerships & Funding

    RoosterBio and Thermo Fisher team up to accelerate cell and exosome therapy manufacturing

    April 29, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno taps global CRO for next big step in pulmonary hypertension drug trial
    Categories: Clinical Trials, Drug Development, Rare Diseases
  • Eleva doses first volunteers with new therapy targeting rare kidney disease
    Categories: Biologics & Biosimilars, Clinical Trials, Drug Development, Rare Diseases
  • First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track
    Categories: Cell & Gene Therapy, Clinical Trials, Rare Diseases, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top